Biomedical Laboratory Science

ShareThis

Friday, August 19, 2016

Theranos – Scientific Breakthrough or Epic Hoax?

A company on the brink of a scientific and medical breakthrough, or a hoax on an epic scale? Russ Swan considers the story of Theranos.

What follows is a tale of laboratory technology, a technological revolution, a precocious main protagonist, and billions of dollars. It is a riches-to-rags tale with elements of the Emperor’s new clothes, more than a bit of hubris, and a tragic twist involving a British scientist.

The story of Theranos and its founder, Elizabeth Holmes, is still playing out. This is what we know so far, and it is truly jaw dropping. It begins with a first year chemical engineering student at Stanford, spending a summer placement in Singapore assisting in the development of a protein microarray for a diagnostics test for Sars. On returning to California, Holmes (for it was she) quickly dropped out of college to set up her own firm to work on similar technologies.



Source: labnews

Monday, August 15, 2016

Diagnosis of Pneumocystis jirovecii pneumonia

Diagnosis of Pneumocystis jirovecii pneumonia (PCP) is conventionally based on direct staining and visualization. Challenges in obtaining alveolar samples have stimulated interest in techniques for detection of Pneumocystis DNA in non-invasive samples, which can give good sensitivity and specificity. Robust diagnosis is key to ensuring appropriate therapy.

Introduction
Pneumocystis jirovecii (previously Pneumocystis carinii) is a pathogen capable of causing life threatening Pneumocystis pneumonia (PCP) in the immunocompromised with case fatality rates among those hospitalized of around 10%. PCP typically occurs in individuals with hematological malignancies on chemotherapy or with other causes of acquired cellular immunodeficiency or, most frequently, in human immunodeficiency virus (HIV)-positive individuals with CD4 T-cell counts <200 cells/µL or <14% of total white cell count. First-line treatment is co-trimoxazole, a combination of the antibiotics sulfamethoxazole and trimethoprim, at high dose for 3 weeks, which has the clinically significant potential side effects of bone marrow suppression, rash and bronchial hypersensitivity.


Sunday, August 14, 2016

Blood Vessel-Forming Protein Could Offer Alternative to Heart Bypass Surgery

For patients with severe coronary artery disease, heart bypass surgery can reduce the risk of heart attack and improve overall quality of life. Now, researchers report the possibility of a new treatment that may be even more beneficial, without the surgery.

Coronary artery disease (CAD) is the most common form of heart disease in the United States, responsible for more than 370,000 deaths in the country every year.

The condition arises when plaque builds up in the coronary arteries, partially or fully blocking the flow of oxygen-rich blood to the heart muscle. This blockage can cause heart attack, angina - severe chest pain - and, over time, heart failure.

While lifestyle changes - such as adopting a healthy diet and regular physical activity - are considered key to improving CAD, some patients may require heart bypass surgery, which can help restore blood flow to the heart.

But, as with all surgery, it has its risks. These include chest wound infection, bleeding, stroke, heart attack, and kidney or lung failure.


Researchers say the protein AGGF1 could be a promising treatment for coronary heart disease and
heart attack.

What Happens to Your Body When You Stop Smoking

The process your body goes through after stopping smoking - in the 20 minutes to 15 years after your last cigarette - has been revealed by CVS health.

Around 10 million people in the UK smoke, and about two thirds of them want to stop, according to research from Action on Smoking and Health (ASH).

About half of all regular smokers will die from their addiction, which amounts to about 100,000 people a year.

The infographic from CVS Health (click to enlarge) revealed that 20-30 minutes after smoking cessation blood pressure and pulse have already started to drop, and the carbon monoxide in the blood will begin to drop after just eight hours.


A year after you stop smoking, your risk of heart disease will be half that of a smoker

HIV: Newly Discovered Component Could Lead to More Effective Drugs

Scientists from the Medical Research Council Laboratory of Molecular Biology in Cambridge and University College London - both in the United Kingdom - have uncovered key components of HIV, which they believe could lead to new approaches for drugs to fight the infection.

HIV weakens a person's immune system by destroying important cells that fight disease and infection. Only certain body fluids - blood, semen, rectal fluids, vaginal fluids, and breast milk - from a person who has HIV can transmit HIV.

According to the Centers for Disease Control and Prevention (CDC), an estimated 1.2 million people are living with HIV in the United States. Although there is no cure for HIV infection, improved treatments allow people living with HIV to slow the virus' progression and stay relatively healthy for several years.

HIV is a part of a subtype of viruses called retroviruses, which means that the virus is composed of RNA - instead of normal DNA - and has the unique property of transcribing RNA into DNA after entering a cell.


Findings from the research could lead to future drugs that can enter human cells and block the pores
from within.

Saturday, August 13, 2016

Thyroid Hormone Receptors and Resistance to Thyroid Hormone Disorders

Thyroid hormone action is predominantly mediated by thyroid hormone receptors (THRs), which are encoded by the thyroid hormone receptor α (THRA) and thyroid hormone receptor β (THRB) genes. Patients with mutations in THRB present with resistance to thyroid hormone β (RTHβ), which is a disorder characterized by elevated levels of thyroid hormone, normal or elevated levels of TSH and goitre.

Mechanistic insights about the contributions of THRβ to various processes, including colour vision, development of the cochlea and the cerebellum, and normal functioning of the adult liver and heart, have been obtained by either introducing human THRB mutations into mice or by deletion of the mouse Thrb gene. The introduction of the same mutations that mimic human THRβ alterations into the mouse Thra and Thrb genes resulted in distinct phenotypes, which suggests that THRA and THRB might have non-overlapping functions in human physiology.

These studies also suggested that THRA mutations might not be lethal. Seven patients with mutations in THRα have since been described. These patients have RTHα and presented with major abnormalities in growth and gastrointestinal function. The hypothalamic–pituitary–thyroid axis in these individuals is minimally affected, which suggests that the central T3 feedback loop is not impaired in patients with RTHα, in stark contrast to patients with RTHβ.


Overview of tissues and homeostatic functions affected in RTHα and RTHβ.

'Living' Cartilage Grown Using Stem Cells Could Prevent Hip Replacement Surgery

An alternative to hip replacement surgery may be in sight. In the Proceedings of the National Academy of Sciences, researchers reveal how it may be possible to use a patient's own stem cells to grow new cartilage in the shape of a hip joint.

Furthermore, the team - including researchers from Washington University School of Medicine in St. Louis, MO - says it is possible to program the newly grown cartilage to release anti-inflammatory molecules, which could stave off the return of arthritis - the most common cause of hip pain.

According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), osteoarthritis is the primary cause of hip joint damage that requires hip replacement surgery, causing severe pain and disability.

Hip replacement surgery, also known as arthroplasty, involves surgically removing the diseased part of the hip and replacing it with new, prosthetic parts. Each year in the United States, more than 332,000 hip replacement surgeries are performed.


Researchers describe how they could use a patient's own stem cells to grow new cartilage that covers
a 3-D scaffold molded to the shape of their hip joint.

Afraid of Failure? Think Like a Scientist and Get Over It

I recently had a wonderful conversation with my friend, Beck Tench. During our chat, Beck told me about an interesting shift in thinking that occurred while she worked at a science museum.

During her time there, Beck said that she learned how to treat failure like a scientist.

How does a scientist treat failure? And what can we learn from their approach?

Here’s what Beck taught me…



Source: entrepreneur

Osteoarthritis can be Caused by Senescent Cells

Researchers have uncovered evidence that cellular senescence - whereby cells stop dividing - is a cause of osteoarthritis, and they suggest targeting these cells could offer a promising way to prevent or treat the condition.

Study co-author Dr. James Kirkland, director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic in Rochester, MN, and colleagues publish their findings in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.

Osteoarthritis (OA), also known as degenerative joint disease, is a condition in which cartilage - the tissue that protects the end of each bone in a joint - wears away, causing the underlying bones to rub together. This can cause pain, swelling, and poor joint movement.

As the condition worsens, the bones may lose shape. Additionally, growths called bone spurs may arise, and bits of bone and cartilage can break off and float around the space in the joint. This can trigger an inflammatory response that exacerbates pain, as well as cartilage and bone damage.


Researchers say that targeting senescent cells may have the potential to prevent or treat osteoarthritis.
Source: medicalnewstoday

Thursday, August 11, 2016

Blood test for Tuberculosis

Together with AIDS, tuberculosis ranks among those infectious diseases with the highest global mortality rate, claiming the lives of between 1.5 and two million people every year. However, not everyone infected with the bacterium develops tuberculosis. In fact, fewer than ten percent of those infected go on to manifest the disease. An international team of scientists, including researchers from the Max Planck Institute for Infection Biology in Berlin, have now developed a tuberculosis test that can reliably predict whether an individual will develop active tuberculosis. Doctors may be able to use this test in future to predict the progression of the disease and initiate medical care early.

In future, molecules from blood samples can tell physicians if somebody will develop tuberculosis.



Source: cli-online
Related Posts Plugin for WordPress, Blogger...

AddToAny